<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20150715023216N13</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-11-20</date_registration>
      <primary_sponsor>Esfahan University of Medical Sciences</primary_sponsor>
      <public_title>The effect of motion-based self-care education on quality of life and life expectancy of patients with COVID-19</public_title>
      <acronym></acronym>
      <scientific_title>The effect of motion-based self-care education on quality of life and life expectancy of patients with COVID-19</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-11-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>40</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/66652</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Simple randomization will be done using permutation block in such a way that intervention group patients will be given code A and control group patients will be given code B, and then the blocks will be determined by lottery and for example  If the first block is AB, it means that the first patient who meets the study entry criteria will be in the intervention group and the second patient who meets the study entry criteria will be in the control group, and we will have twenty blocks in total, Blinding description: In this project, the data analyst will not be aware of which patients are in the intervention group and which are in the control group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>COVID19.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:  Intervention group: Receiving self-care education motion graphics (in the areas of feeding patients during the recovery period, how to take drugs and drug and nutritional interactions, principles of appropriate quarantine in a separate room or a shared room, using a shared toilet and bathroom with other family members or Separately, the principles of disposing of patient waste, the duration of quarantine and issues related to after leaving quarantine, points related to the possibility of re-infection with COVID-19, the time of corona vaccine injection, signs and symptoms of worsening of the disease, respiratory physiotherapy and psychological issues. Related to the quarantine period and topics related to fasting in the holy month of Ramadan in patients with COVID-19). Intervention 2: Control group: Control group: receiving training in the areas of nutrition of patients during the recovery period, how to take drugs and drug and nutritional interactions, the principles of appropriate quarantine in a separate room or a shared room, using a shared toilet and bathroom with other family members or separately. , the principles of disposing of patient waste, the duration of quarantine and issues related to after leaving quarantine, points related to the possibility of re-infection with Covid-19, the time of corona vaccine injection, signs and symptoms of worsening of the disease, respiratory physiotherapy and related psychological issues To the quarantine period and topics related to fasting in the holy month of Ramadan in patients with covid-19 in PDF format.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is disinclination</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ahmad Ghadam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hezarjerib Street, Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673461</zip>
        <telephone>+98 31 3792 7583</telephone>
        <email>ghadami@nm.mui.ac.ir</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Morteza Pourahmad</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Unit No304, second floor, Arman Medical Complex, Alley number 5, Tayyab St, Isfahan, Iran</address>
        <city>Isfahan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>8174673465</zip>
        <telephone>+98 31 3220 8571</telephone>
        <email>mortezapourahmad@yahoo.com</email>
        <affiliation>Esfahan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All patients have full consent to participate in the study.
Patients only need home quarantine.
The patients of the intervention group should have mobile phones with the ability to run motion graphics.
Control group patients should have mobile phones with the ability to run PDF.
Control group patients should have enough literacy to read and use PDF.
Intervention group patients should have good hearing.
Patients should be in the age range of 20-65 years.
No cancer diseases, no history of organ transplant surgeries and no use of drugs that weaken the immune system.</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>The people present in the study are not willing to continue cooperating with the research team at any stage of the research and for any reason.
Worsening of the disease and requiring hospitalization.
Failure to complete or incomplete completion of any of the quality of life and life expectancy questionnaires.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J98</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other respiratory disorders</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Lifestyle</i_code>
      <i_code>Lifestyle</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:  Intervention group: Receiving self-care education motion graphics (in the areas of feeding patients during the recovery period, how to take drugs and drug and nutritional interactions, principles of appropriate quarantine in a separate room or a shared room, using a shared toilet and bathroom with other family members or Separately, the principles of disposing of patient waste, the duration of quarantine and issues related to after leaving quarantine, points related to the possibility of re-infection with COVID-19, the time of corona vaccine injection, signs and symptoms of worsening of the disease, respiratory physiotherapy and psychological issues. Related to the quarantine period and topics related to fasting in the holy month of Ramadan in patients with COVID-19).</i_keyword>
      <i_keyword>Control group: Control group: receiving training in the areas of nutrition of patients during the recovery period, how to take drugs and drug and nutritional interactions, the principles of appropriate quarantine in a separate room or a shared room, using a shared toilet and bathroom with other family members or separately. , the principles of disposing of patient waste, the duration of quarantine and issues related to after leaving quarantine, points related to the possibility of re-infection with Covid-19, the time of corona vaccine injection, signs and symptoms of worsening of the disease, respiratory physiotherapy and related psychological issues To the quarantine period and topics related to fasting in the holy month of Ramadan in patients with covid-19 in PDF format</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The quality of life score from the standard quality of life questionnaire SF-36 in patients with COVID-19. Timepoint: The measurement of quality of life at the beginning of the study (before the intervention) and 14 days after receiving self-care training at home. Method of measurement: Standard questionnaire of quality of life SF-36.</prim_outcome>
      <prim_outcome>Life expectancy score from Snyder's standard life expectancy questionnaire in patients with COVID-19. Timepoint: The measurement of Life expectancy at the beginning of the study (before the intervention) and 14 days after receiving self-care training at home. Method of measurement: Standard Snyder Life Expectancy Questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Esfahan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-11-02</approval_date>
        <contact_name>Ethics committee of Isfahan University of Medical Sciences</contact_name>
        <contact_address>Hezarjerib Street, Isfahan, Iran Isfahan Isfehan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
